OBM Geriatrics is an Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.
Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.
Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.
Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes research articles, reviews, communications and technical notes. There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2020, 1-2 days of FREE language polishing time is also included in this period).
Geriatric Nutrition Management
Submission Deadline: November 30, 2021 (Open) Submit Now
Carlo Pedrolli, MD
Dietetic and Clinical Nutrition Unit, Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari Provincia Autonoma di Trento, Largo Medaglie d’Oro 9, Trento 38122, Italy
Research Interests: Nutrition; geriatric nutrition; internal medicine; cardiology; clinical nutrition; malnutrition; nutrition assessment; human nutrition; nutritional medicine; body composition analysis; dietetics
About This Topic
Management of geriatric nutrition doesn’t just mean to feed ill people; there are many old people in a good shape, who like to travel, to make sport that with very little food intervention could improve quite a lot their quality of life.
On the other side there are people with one or more illness, sometimes metabolic illness (ie diabetes, gout, hypertension, dyslipidaemias, etc) together with neoplastic illness, or survived to a stroke, or affected by a chronic heart failure or chronic renal failure but also affected for example by dysphagia, that correctedly faced can be even if not beaten at least ameliorated; they need much effort to improve their situation; sometimes to improve nutrition doesn’t mean to heal but just to improve quality of life, to improve sarcopenia, to walk some meters more, and sometimes this means to maintain proper autonomy.
So the aim of “Geriatric Nutrition Management” is to uptodate the nutritional screening looking for old people who are malnourished and they do not know; to uptodate the nutritional assessment in people who have a nutritional risk to be confirmed. And to uptodate nutritional intervention, at first by nutritional counseling with food fortification, tackling nutritional support first of all with oral nutritional support (ONS) and/or with artificial nutrition (enteral nutrition or parenteral nutrition or both) when the oral route is no more usable.
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.